Geninus Inc.
GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia. It offers tarhet and biomarker discovery; AI digital pathology; single cell analysis; and spatial and in-situ transcriptomics services; and SPACEINSIGHT, a cutting-edge cloud based integrated analysis platform. It… Read more
Geninus Inc. (389030) - Total Liabilities
Latest total liabilities as of September 2025: ₩24.41 Billion KRW
Based on the latest financial reports, Geninus Inc. (389030) has total liabilities worth ₩24.41 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Geninus Inc. - Total Liabilities Trend (2018–2024)
This chart illustrates how Geninus Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Geninus Inc. Competitors by Total Liabilities
The table below lists competitors of Geninus Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fullerton Technology Co Ltd
TW:6136
|
Taiwan | NT$363.19 Million |
|
G2Power Co. Ltd.
KQ:388050
|
Korea | ₩50.51 Billion |
|
Granite Point Mortgage Trust Inc
NYSE:GPMT
|
USA | $1.20 Billion |
|
Bigtincan Holdings Limited
PINK:BTGHF
|
USA | $96.12 Million |
|
Lotte Non-Life
KO:000400
|
Korea | ₩14.29 Trillion |
|
Intermap Technologies Corp
OTCQX:ITMSF
|
USA | $5.55 Million |
|
Sanurhasta Mitra PT
JK:MINA
|
Indonesia | Rp13.06 Billion |
|
Go Fashion (India) Limited
NSE:GOCOLORS
|
India | ₹6.26 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down Geninus Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Geninus Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Geninus Inc. (2018–2024)
The table below shows the annual total liabilities of Geninus Inc. from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩10.85 Billion | +79.64% |
| 2023-12-31 | ₩6.04 Billion | +136.01% |
| 2022-12-31 | ₩2.56 Billion | -58.42% |
| 2021-12-31 | ₩6.16 Billion | -85.21% |
| 2020-12-31 | ₩41.62 Billion | +173.75% |
| 2019-12-31 | ₩15.20 Billion | +510.18% |
| 2018-12-31 | ₩2.49 Billion | -- |